Figure 1 | Scientific Reports

Figure 1

From: EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

Figure 1

Immunochemical analysis of FSCN1 and EGFR expression in breast tissue specimens (magnification ×200). (A) UDH. FSCN1 expression is negative in proliferative ductal epithelial cells. (B) DCIS. FSCN1 expression is negative in intraductal cancer cells. (C) non-TNBC. Fascin-1 expression is positive in cancer cells. (D) TNBC. FSCN1 expression is strongly positive in cancer cells. (E) non-TNBC. EGFR expression is negative in cancer cells. (F) TNBC. EGFR expression is positive in cancer cells.

Back to article page